Prognostic potential of lipid profiling in cancer patients: a systematic review of mass spectrometry-based studies
Y Takanashi, T Kahyo, K Sekihara, A Kawase… - Lipids in Health and …, 2024 - Springer
Cancer prognosis remains a critical clinical challenge. Lipidomic analysis via mass
spectrometry (MS) offers the potential for objective prognostic prediction, leveraging the …
spectrometry (MS) offers the potential for objective prognostic prediction, leveraging the …
Castration-resistant prostate cancer monitoring by cell-free circulating biomarkers
E Chrenková, H Študentová, K Holá… - Frontiers in …, 2024 - pmc.ncbi.nlm.nih.gov
Background Prostate cancer is the second leading cause of male cancer-related deaths in
Western countries, which is predominantly attributed to the metastatic castration-resistant …
Western countries, which is predominantly attributed to the metastatic castration-resistant …
Evolocumab in metastatic castration-resistant prostate cancer: study protocol for a single-arm, phase II trial, and initial experience with use of a validated lipid …
R Mellor, L Ardolino, T Scheinberg… - Therapeutic …, 2024 - journals.sagepub.com
Background: Despite advances in the treatment of metastatic castration-resistant prostate
cancer (mCRPC), primary and secondary resistance to current therapies remains. Elevated …
cancer (mCRPC), primary and secondary resistance to current therapies remains. Elevated …